NAD Breakthrough

Jin-Xiong She
PhD, Founder, CEO & Chief Scientific Officer

This is an exciting time for users of our NAD assays and our Vitality Boost product. Science and research continue to validate what we do at Jinfiniti Precision Medicine. A recently published study should give you even more reason to value your use of our products.

Our Founder, Dr. Jin-Xiong She, explains. “The study, released in Nature Cardiovascular Research on Feb 13, was great news for not only Jinfiniti users, but for the hundreds of thousands of people who suffer from heart disease, especially those who have no idea that they do.” As a research scientist, Professor, academician, and the developer of products that not only test, but measure, intracellular NAD levels, Dr. She’s work creating the NAD supplements and testing measures that we offer is validated by this study.

He explains the importance of it further, saying, “Researchers discovered one of the earliest signs of heart failure, energy production dysregulation. “Why this is important is that formerly we believed that this energy shortage was associated with later stage heart failure. This study shows that it’s actually one of the earliest signs of heart failure,” he adds.

The researchers were able to identify a decline in energy production that occur well before the deterioration or damage that had formerly been identified in a later stage. Early intervention could modify the events that would inevitably occur down the line once the energy is dysregulated, helping to prevent further deterioration or heart failure.

He concludes. “A heart that has dysregulated energy is a heart that is deficient in NAD.”

Category: Blog